A randomized, open-label, single-centre drug-drug interaction Phase 1 study to assess the safety, tolerability and pharmacokinetics of OBE022 when co-administered with medications typically used in women with pre-term labour

Trial Profile

A randomized, open-label, single-centre drug-drug interaction Phase 1 study to assess the safety, tolerability and pharmacokinetics of OBE022 when co-administered with medications typically used in women with pre-term labour

Completed
Phase of Trial: Phase I

Latest Information Update: 25 May 2017

At a glance

  • Drugs OBE 022 (Primary) ; Atosiban; Betamethasone; Nifedipine
  • Indications Preterm labour
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 May 2017 New trial record
    • 18 May 2017 Results published in an ObsEva media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top